Massachusetts Financial Services CO Shockwave Medical, Inc. Transaction History

Massachusetts Financial Services CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$191.17 - $325.63 $20.7 Million - $35.2 Million	-108,105 Reduced 48.13%	116,484 $37.9 Million
Q4 2023 Feb 08, 2024	BUY	$160.99 - $215.69 $8.13 Million - $10.9 Million	50,478 Added 28.99%	224,589 $42.8 Million
Q3 2023 Nov 08, 2023	BUY	$194.33 - $283.97 $2.74 Million - $4.01 Million	14,106 Added 8.82%	174,111 $34.7 Million
Q2 2023 Aug 09, 2023	BUY	$223.05 - $302.68 $2.44 Million - $3.31 Million	10,951 Added 7.35%	160,005 $45.7 Million
Q1 2023 May 10, 2023	BUY	$175.41 - $217.92 $26.1 Million - $32.5 Million	149,054 New	149,054 $32.3 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.